Differential effects of THC- or CBD-rich cannabis extracts on working memory in rats

Neuropharmacology

Volumn 47, Issue 8, 2004, Pages 1170-1179

  Fadda, Paola ^a,b   Robinson, Lianne ^a   Fratta, Walter ^b   Pertwee, Roger G ^a   Riedel, Gernot ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Cannabidiol; Cannabis extract; Rat; THC; Water maze; Working memory

Indexed keywords

CANNABIDIOL; CANNABIS; DRONABINOL;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALEPSY; CONTROLLED STUDY; DOSE RESPONSE; MALE; MAZE TEST; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RAT; RAT STRAIN; SHORT TERM MEMORY; SPATIAL MEMORY; TASK PERFORMANCE; WORKING MEMORY;

ANIMALS; CANNABIDIOL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MAZE LEARNING; MEMORY; PLANT EXTRACTS; RATS; RECEPTOR, CANNABINOID, CB1; TETRAHYDROCANNABINOL;

EID: 9644302602     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2004.08.009     Document Type: Article

References (56)

1. Berrendero F., Maldonado R. Involvement of the opioid system in the anxiolytic-like effects induced by delta(9)-tetrahydrocannabinol. Psychopharmacology. 163:2002;111-117
2. Block R.I., Ghoneim M.M. Effects of chronic marijuana use in human cognition. Psychopharmacology. 110:1993;219-228
3. Costall B., Olley J.E. Cholinergic and neuroleptic induced catalepsy: modification by lesions in the caudate-putamen. Neuropsychopharmacology. 10:1971;297-306
4. 9- tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology. 164:2002;61-70
5. 9- tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 26:2002;321-325
6. Darley C.F., Tinklenberg J.R., Roth W.T., Atkinson R.C. The nature of storage deficits and state-dependent retrieval under marijhuana. Psychopharmacology. 37:1974;139-149
7. 9-tetrahydrocannabinol: search for the impairment of spatial memory in the eight-arm radial maze in rats. Brain Res. 952:2002;239-245
8. Evans A.T., Formukong E., Evans F.J. Actions of cannabis constituents on enzymes of arachidonate metabolism: anti-inflammatory potential. Biochem. Pharmacol. 36:1987;2035-2037
9. Fletcher J.M., Page J.B., Francis D.J., Copeland K., Naus M.J., Davis C.M., Morris R., Krausskopf D., Satz P. Cognitive correlates of long-term cannabis use in Costa Rican men. Arch. Gen. Psychiatr. 53:1996;1051-1057
10. Guimarães F.S., Chiaretti T.M., Graeff F.G., Guardi A.W. Antianxiety effect of cannabidiol in the elevated plus-maze. Psychopharmacology. 100:1990;558-559
11. 9-tetrahydrocannabinol are neuroprotective antioxidants. Proc. Natl. Acad. Sci. USA. 95:1998;8268-8273
12. Hampson R.E., Deadwyler S.A. Role of the cannabinoid receptors in memory storage. Neurobiol. Dis. 5:1998;474-482
13. Hampson R.E., Deadwyler S.A. Cannabinoids, hippocampal function and memory. Life Sci. 65:1999;715-723
14. Hampson R.E., Deadwyler S.A. Cannabinoids reveal the necessity of hippocampal neural encoding for short-term memory in rats. J. Neurosci. 20:2000;8932-8942
15. 9-tetrahydrocannabinol in humans. Psychopharmacology. 164:2002;407-415
16. 9-THC on exploratory behaviour and memory in the rat. J. Physiol. Biochem. 56:2000;17-24
17. 9- tetrahydrocannabinol on delayed match to sample performance in rats: alterations in short-term memory associated with changes in task specific firing of hippocampal cells. J. Pharmacol. Exp. Ther. 264:1993;294-307
18. Izquierdo I., Nasello A.G. Effects of cannabidiol and diphenylhydantoin on the hippocampus and learning. Psychopharmacologia. 31:1973;167-175
19. Jacobsson S.O.P., Rongard E., Stridh M., Tiger G., Fowler C.J. Serum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viability. Biochem. Pharmacol. 60:2000;1807-1813
20. 9-Tetrahydrocannabinol increases prefrontal cortical catecholaminergic utilization and impairs spatial working memory in the rat: blockade of dopaminergic effects by HA966. Neuropsychopharmacology. 16:1997;426-432
21. Karler R., Turkanis S.A. The cannabinoids as potential antiepiletiptics. J. Clin. Pharmacol. 21:1981;437S-448S
22. 9-tetrahydrocannabinol. Psychopharmacologia. 33:1973;53-70
23. Lichtman A.H., Dimen K.R., Martin B.R. Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology. 119:1995;282-290
24. 9-Tetrahydrocannabinol impairs spatial memory through cannabinoid receptor mechanism. Psychopharmacology. 126:1996;125-131
25. Lichtman A.H. SR141716A enhances spatial memory as assessed in a radial-arm maze task in rats. Eur. J. Pharmacol. 404:2000;175-179
26. Lindner M.D. Reliability, distribution, and validity of age-related cognitive deficits in the Morris water maze. Neurobiol. Learn. Mem. 68:1997;203-220
27. Mallet P.E., Beninger R.J. The endogenous cannabinoid receptor agonist anandamide impairs memory in rats. Behav. Pharmacol. 7:1996;276-284
28. 9-tetrahydrocannabinol or anandamide. Psychopharmacology. 140:1998;11-19
29. Miller L.L., Branconnier R.J. Cannabis: effects on memory and the cholinergic limbic system. Psychol. Bull. 93:1983;441-456
30. 9-tetrahydrocannabinol in rats. Jpn. J. Pharmacol. 87:2001;297-308
31. 9-tetrahydrocannabinol on short-term memory in the rat. Physiol. Behav. 57:1995;177-179
32. Morris R.G.M., Moser E.I., Riedel G., Martin S.J., Sandin J., Day M., O'Carroll C. Elements of a neurobiological theory of the hippocampus: the role of activity-dependent synaptic plasticity in memory. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 358:2003;773-786
33. Musty R.E. Possible anxiolytic effects of cannabidiol. Agurell S., Dewey W.L., Willette R.E. The Cannabinoids: Chemical, Pharmacologic and Therapeutic Aspects. 1984;785-813 Academic Press, Orlando
34. Nakamura E.M., Da Silva E.A., Concilio G.V., Wilkinson D.A., Masur J. Reversible effects of acute and long-term administration of Δ-9- tetrahydrocannabinol (THC) on memory in the rat. Drug Alcohol Depend. 28:1991;167-175
35. 9-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alteration performance in the T-maze. Neuropharmacology. 41:2001;392-399
36. Onaivi E.S., Green M.R., Martin B.R. Pharmacological characterization of cannabinoids in the elevated plus maze. J. Pharmacol. Exp. Therap. 254:1990;11002-11009
37. Pertwee R.G. The central neuropharmacology of psychotropic cannabinoids. Pharmacol. Ther. 36:1988;189-261
38. Pertwee R.G. The pharmacology and therapeutic potential of cannabidiol. Di Marzo V. Cannabinoids. 2004;32-83 Kluwer Academic
39. Robinson L., Riedel G. Cannabinoid function in spatial learning: an update. Curr. Neuropharm. 2:2004;125-143
40. Robinson L., Pertwee R.G., Riedel G. Differential effects of CB1 receptor antagonists HU210 and WIN 55,212-2 on working memory in rats. Behav. Pharmacol. 12:2001;S84
41. Rodriguez de Fonseca F., Carrera M.R.A., Navarro M., Koob G.F., Weiss F. Activation of corticotrophin-releasing factor in the limbic system during cannabinoid withdrawal. Science. 276:1997;2050-2054
42. Sandyk R., Snider S.R., Consroe P., Elias S.M. Cannabidiol in dystonic movement disorders. Psychiatry Res. 18:1986;291
43. Sañudo Peña M.C., Romero J., Seale G.E. Activational role of cannabinoids on movements. Eur. J. Pharmacol. 391:2000;269-274
44. Sofia R.D., Knobloch L.C., Vassar H.B. The anti-edema activity of various naturally occurring cannabinoids. Res. Commun. Chem. Pathol. Phamacol. 6:1973;909-918
45. Steele R.J., Morris R.G. Delay-dependent impairment of a matching-to-place task with chronic and intrahippocampal infusion of the NMDA antagonist D-AP5. Hippocampus. 9:1999;118-136
46. Stiglick A., Kalant H. Learning impairment in the radial-arm maze following prolonged cannabis treatment in rats. Psychopharmacology. 77:1982;117-123
47. 9-THC on spatial reference and working memory in mice. Psychopharmacology. 157:2001;142-150
48. 1 receptor knockout mice in the Morris water maze. J. Pharmacol. Exp. Ther. 301:2002;915-924
49. Von Linstow Roloff E., Platt B., Riedel G. Long term study of chronic oral aluminium exposure and spatial working memory in rats. Behav. Neurosci. 116:2002a;351-356
50. Von Linstow Roloff E., Platt B., Riedel G. No spatial working memory deficit in beta-amyloid-exposed rats: a longitudinal study. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 26:2002b;955-970
51. Wallace M.J., Wiley J.L., Martin B.R., DeLorenzo R.J. Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects. Eur. J. Pharmacol. 428:2001;51-57
52. Welburn P.J., Starter G.A., Chesher G.B., Jackson D.M. Effect of cannabinoids on the abdominal constriction response in mice: within cannabinoid interactions. Psychopharmacology. 46:1976;83-85
53. Whishaw I.Q. Latent learning in swimming pool place task in rats: evidence for the use of associative and not cognitive mapping processes. Q. J. Exp. Psychol. 43:1991;83-103
54. Winsauer P.J., Lambert P., Moerschbaecher J.M. Cannabinoid ligands and their effects on learning and performance in rhesus monkeys. Behav. Pharmacol. 10:1999;497-511
55. 9-THC in normal subjects. Psychopharmacology. 76:1982;245-250
56. 9-tetrahydrocannabinol and cannabidiol, separately and in combination. Braz. J. Med. Biol. Res. 16:1983;141-146